Physician profile
Christopher M Simons
NPI 1962997353
$5,458.69
in general payments reported to CMS, 2019-2025
16 companies · $99.68 in 2025
The $99.68 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $125 · 2021: $283 · 2022: $42.93 · 2023: $150 · 2024: $4,582 · 2025: $99.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,600 · Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,600.00 |
| Food and Beverage | $231.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,623.42 | 2023-2024 | Davinci Xi |
| Therapeuticsmd, INC. | $239.25 | 2019-2021 | |
| Conmed Corporation | $128.43 | 2019-2021 | |
| Baxter Healthcare | $103.06 | 2021 | |
| Sage Therapeutics, LLC | $66.82 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $63.17 | 2021 | |
| Pfizer INC. | $50.01 | 2023-2024 | |
| Medtronic, INC. | $42.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.79 | 2024 | |
| Amag Pharmaceuticals, INC. | $23.84 | 2020 | |
| Meditrina | $17.00 | 2023 | |
| Exeltis, USA INC. | $16.82 | 2023 | Slynd |
| Evofem Biosciences, INC. | $16.79 | 2025 | Solosec, Phexx, Phexxi |
| Supernus Pharmaceuticals, INC. | $16.07 | 2025 | Qelbree |
| Coopersurgical, INC. | $15.29 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.